Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World.

Akinori MinatoRieko KimuroDaichi OhnoKentarou TanigawaKeisuke KuretakeTakuo MatsukawaTomohisa TakabaKazumasa JojimaMirii HaradaKatsuyoshi HigashijimaYujiro NagataIkko TomisakiKenichi HaradaNaohiro FujimotoHiroshi Miyamoto

Published in: Anticancer research (2023)

EV monotherapy demonstrated promising anti-tumor activity and tolerability in patients with metastatic urothelial carcinoma.

Keyphrases

open label
squamous cell carcinoma
small cell lung cancer
clinical trial
placebo controlled
double blind
hodgkin lymphoma
study protocol
combination therapy
randomized controlled trial